CONCLUSIONS: We identified anticipated facilitators and barriers to inform a clinical trial of IPT-B for maternal depression treatment in an urban asthma clinic. Addressing these determinants prior to implementation will support co-located treatment, meeting a critical need for mothers and advancing health equity in this population.
